Environmental Proteinases in Human/Experimental Asthma
Environmental Proteinases in Human/Experimental Asthma
批准号:
7150845
负责人:
DAVID B CORRY
金额:
$26.32万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2011-06-30
关键词:
airborne allergenallergensasthmabiological signal transductionchildrendevelopmental immunologydisease /disorder etiologydisease /disorder modeldustendopeptidasesenvironmental exposureenzyme activityfungal proteinshuman subjectimmunityinflammationlaboratory mousemolecular pathologypathologic processrespiratory hypersensitivity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broad, long-term objectives of this laboratory are to understand the immunological mechanisms
underlying allergic lung disease. This proposal specifically will determine the earliest innate immune
signaling pathway activated by allergens that conditions the lung for subsequent allergic lung disease.
Further, we will determine the relationship between allergenic proteinases in home environments and the
development of childhood asthma. Recent studies indicate that allergic asthma is the result of failure of
immune tolerogenic mechanisms that are normally activated to suppress inflammatory responses to
inhaled antigens. Commonly used experimental allergens such as ovalbumin are only transiently capable
of avoiding tolerance and inducing robust airway inflammation and then only if administered initially
remotely from the lung followed by airway antigen challenge. In contrast, we have developed more potent
allergens derived from sources implicated in human allergic disease. Without requiring special adjuvants
or protocols for administration, these fungal and pollen-derived allergens strongly induce allergic lung
inflammation by bypassing airway immune tolerogenic mechanisms. These potent allergens contain strong
proteinase activities that account entirely for their ability to induce and sustain chronically the asthma
phenotype. Although non-fungal proteinases exist and are implicated in human asthma and other allergic
disorders, our data indicate that dust from homes of asthmatic children contains primarily fungal
proteinases.
We therefore propose the novel hypothesis that proteinases represent an essential environmental adjuvant
factor that is responsible for inducing allergic disease, especially in early life. The aims of this proposal are
therefore to: 1. To evaluate the association between fungal proteinases and childhood asthma; and 2. To
functionally characterize a novel innate signaling pathway of the airway activated by proteolytic allergen.
We will conduct a case-control study involving Houston-area children with and without asthma to
understand the association between active proteinase in house dust and asthma and, further, prepare
allergens from fungi isolated from homes of asthmatic children and determine the innate immune
mechanism by which they elicit disease in mice. This proposal links human and animal studies to unravel
the fundamental immune mechanisms underlying allergic inflammation with the intent to develop novel
therapies for asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular and Cellular Dissection of miRNAs in Controlling Allergic Airway Inflammation in Mice
-
批准号:10477187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
Molecular and Cellular Dissection of miRNAs in Controlling Allergic Airway Inflammation in Mice
-
批准号:10664926
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
IMPACC-MEDVAMC
-
批准号:10202368
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
Molecular and Cellular Dissection of miRNAs in Controlling Allergic Airway Inflammation in Mice
-
批准号:10012111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
IMPACC-MEDVAMC
-
批准号:10265764
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
-
批准号:10240489
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
-
批准号:10470262
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
Pathogenesis of Polymicrobial Cerebritis-Related Dementia
-
批准号:10119639
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
FUNGAL PATHOGENESIS OF MODERATE TO SEVERE ASTHMA
-
批准号:10357580
-
项目类别:
-
资助金额:$50.52万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
-
批准号:9766362
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
-
批准号:10001079
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
STAT Inhibitors for Asthma Therapy
-
批准号:9202192
-
项目类别:
-
资助金额:$22.75万
-
财政年份:2016
-
负责人:DAVID B CORRY
-
依托单位:
Th1 and Th17 Mediators in Experimental Emphysema
-
批准号:9085352
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Th1 and Th17 Mediators in Experimental Emphysema
-
批准号:8510061
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Th1 and Th17 Mediators in Experimental Emphysema
-
批准号:8701133
-
项目类别:
-
资助金额:$38.34万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Carbon Black Induced Activation of Lung APCs
-
批准号:8542423
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Carbon Black Induced Activation of Lung APCs
-
批准号:8670556
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Molecular Phenotypes for Lung Diseases
-
批准号:7691799
-
项目类别:
-
资助金额:$69.25万
-
财政年份:2008
-
负责人:DAVID B CORRY
-
依托单位:
Molecular Phenotypes for Lung Diseases
-
批准号:7902047
-
项目类别:
-
资助金额:$69.22万
-
财政年份:2008
-
负责人:DAVID B CORRY
-
依托单位:
Molecular Phenotypes for Lung Diseases
-
批准号:8112589
-
项目类别:
-
资助金额:$68.73万
-
财政年份:2008
-
负责人:DAVID B CORRY
-
依托单位:
海外基金